News

In November 2020, the European Court of Justice published a judgement stating that cannabidiol extracted from the cannabis plant should not be considered a drug under the 1961 United Nations Single Convention...

The EMCDDA and Serbia signed a new Working Arrangement this month, which will pave the way for greater cooperation on monitoring the drug phenomenon in Europe and beyond its borders. Due to...

Evidence updates on social reintegration and employment-focused interventions Employment is one of the strongest predictors of positive outcomes for persons with substance use disorder. Unemployed clients in treatment often report that their...

It was with great sadness that the EMCDDA learned of the passing of Richard Hartnoll on 8 December, following a long illness. Richard made a major contribution to the development of the...

United States On 3 November 2020, in tandem with the US presidential election, the four states of Arizona, Montana, New Jersey and South Dakota voted on and approved proposals to introduce systems...

There are signs that a methamphetamine industry is taking hold in Afghanistan, according to a new report published today by the EU drugs agency (EMCDDA) . The paper — Emerging evidence of...

Representatives of candidate, potential candidate and neighbouring countries of the EU are joining members of the EMCDDA’s Reitox network this week (23–27 November) for the agency’s ninth Reitox week. The purpose of...

The EMCDDA Scientific Committee has elected its new Chair and Vice-Chair for the period 2020–22. Prof. Dr. Catherine Comiskey (Ireland) was elected to the position of Chair and Prof. Dr. Henri Bergeron...

Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there are concerns over potentially risky cannabis use and the challenges posed by new addictive behaviours. These are among...

By Gregor Burkhart, Principal scientific analyst — prevention, EMCDDA When the EMCDDA began its operations in 1995, it was clear that the understanding and narrative on prevention had to change. What was...

The latest European data and analysis on substance use and risk behaviours among 15–16-year-old school students will be released in a new report on 12 November. The findings are based on a...

Substitution treatment for stimulants users? Finding a pharmacological treatment for stimulant users has been a research priority for the last decade. Many classes of drugs have been tested: antidepressants, dopamine agonists, antipsychotics...

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are pleased to open registration today for two upcoming joint events in 2021: the European Drugs Winter School (EDWS) and the European Drugs...

This content was published in the EU4MD update released on 01.10.2020. This update also presents a section on studies, upcoming events, and a research corner. Focus on the impact of COVID-19 on...

This month, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe . The journey begins with the first report describing...

The EMCDDA and Kosovo * are signing a new Working Arrangement today which will pave the way for greater cooperation on monitoring the drug phenomenon in Europe and beyond its borders. Dignitaries...

The expansion of contactless drug dealing, the increase in the use of licit drugs and the adaptation of drug treatment protocols during lockdown are among the findings highlighted today in a new...

High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report 2020...

Occasion: Virtual event, European Drug Report 2020: Trends and Developments — Key findings Introduction Good morning, It is my pleasure to present to you the new report on the drug situation in...

How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production...